[Digestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients]

Nephrol Ther. 2009 Jun;5(3):214-6. doi: 10.1016/j.nephro.2009.01.002. Epub 2009 Mar 9.
[Article in French]

Abstract

Administered to reduce hyperkaliema in patients with chronic renal failure, sodium polystyrene sulfonate (Kayexalate) can cause digestive complications. The most severe complication could be the intestinal necrosis or perforation. In the present report, we evoke these complications and illustrate them with some pictures from personal observations.

Publication types

  • English Abstract

MeSH terms

  • Humans
  • Intestinal Diseases / chemically induced*
  • Polystyrenes / adverse effects*
  • Renal Dialysis*

Substances

  • Polystyrenes
  • polystyrene sulfonic acid